Cromwell Holdings’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Buy
6,115
+930
+18% +$217K 0.7% 25
2026
Q1
$1.27M Buy
5,185
+355
+7% +$82.7K 0.71% 17
2025
Q4
$1,000K Buy
4,830
+11
+0.2% +$2.17K 0.55% 25
2025
Q3
$894K Buy
4,819
+123
+3% +$21.1K 0.48% 30
2025
Q2
$717K Sell
4,696
-509
-10% -$78.2K 0.44% 34
2025
Q1
$863K Buy
5,205
+524
+11% +$82K 0.56% 28
2024
Q4
$677K Sell
4,681
-453
-9% -$70.2K 0.39% 36
2024
Q3
$832K Buy
5,134
+46
+0.9% +$7.33K 0.53% 28
2024
Q2
$744K Buy
+5,088
New +$757K 0.45% 35

Other funds holding JNJ

Cromwell Holdings's JNJ Position: Q2 2026 in Review

Cromwell Holdings increased its Johnson & Johnson (JNJ) stake by 18% in Q2 2026, buying an estimated $217K and bringing the position to 6,115 shares worth $1.55M. The position accounts for 0.7% of the portfolio, ranked #25.

Cromwell Holdings first reported a position in JNJ in Q2 2024 and has held it in 9 quarters since. 4,098 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cromwell Holdings held 6,115 shares of Johnson & Johnson worth $1.55M as of Q2 2026.
  • Cromwell Holdings bought 930 Johnson & Johnson shares in Q2 2026, an estimated $217K.
  • Johnson & Johnson made up 0.7% of Cromwell Holdings's portfolio in Q2 2026, its #25 holding.
  • Cromwell Holdings first reported a position in Johnson & Johnson in Q2 2024 and has held it in 9 quarters since.
  • 4,098 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.